Data / Form D filings / ARTERICA INC.
ARTERICA INC.: Form D filings
ARTERICA INC., a biotechnology company in Santa Rosa, CA, filed 3 Form D notices with the SEC between 2019 and 2023. The latest, on May 17, 2023, reports $2.5 million sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3617 Westwind Blvd, Santa Rosa, CA, 95403
- Phone
- (707) 757-7351
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1782224
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 17, 2023 | New notice | $5,000,000 | $2,500,000 | $2,500,000 | 1 | May 12, 2023 | sec.gov |
| Oct 26, 2021 | New notice | $1,000,000 | $805,000 | $195,000 | 10 | Oct 25, 2021 | sec.gov |
| Jul 11, 2019 | New notice | $3,000,000 | $3,000,000 | 1 | Jul 2, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tobias Tullberg | Director | |
| Thomas Larzon | Director | |
| Robert Whirley | Executive Officer, Director | |
| Charlie Rampersaud | Director | |
| Thorsten Siess | Director | |
| Joseph Humphrey | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 15, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ARTERICA INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.